Results 161 to 170 of about 6,506,858 (262)

Genomics insight on passion fruit viral disease complexity. [PDF]

open access: yesMicrobiol Spectr
Munguti F   +4 more
europepmc   +1 more source

The SHERLOCK Platform: An Insight into Advances in Viral Disease Diagnosis. [PDF]

open access: yesMol Biotechnol, 2023
Zahra A   +4 more
europepmc   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato   +27 more
wiley   +1 more source

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease. [PDF]

open access: yesFront Med (Lausanne), 2022
Herzog S   +4 more
europepmc   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

open access: yesArthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin   +7 more
wiley   +1 more source

Detection of pathogenic viruses in the urban wastewater in Kuwait-implications for monitoring viral disease outbreaks. [PDF]

open access: yesEnviron Monit Assess, 2023
Jamil K   +9 more
europepmc   +1 more source

Clinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study

open access: yesArthritis Care &Research, EarlyView.
Objective In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods Electronic records of a multisite cohort (patients
Syed B. Ali   +11 more
wiley   +1 more source

Viral Diseases Explorer: a webtool to identify viral disease information derived from multiple LLMs. [PDF]

open access: yesBioinformatics
Rojas Labra O   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy